Molecular Hybridization: A revolution in contemporary drug development - Randhawa, Palwinder Singh;Shaveta, Shaveta
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Over the last few years, the use of hybrid molecules has increased exponentially in developing new drugs. In comparison to the use of cocktail of drugs, the hybrid molecules provide the advantage of combining together the pharmacophores of two or more drugs and thereby result into the improvement in the medicinal profile of the molecule. This book provides an overview of the hybrid molecules that have been successfully developed for targeting fungal, tubercular, malarial, inflammatory and cancer diseases. Each of the categories of diseases has been discussed separately. The account of hybrid…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Over the last few years, the use of hybrid molecules has increased exponentially in developing new drugs. In comparison to the use of cocktail of drugs, the hybrid molecules provide the advantage of combining together the pharmacophores of two or more drugs and thereby result into the improvement in the medicinal profile of the molecule. This book provides an overview of the hybrid molecules that have been successfully developed for targeting fungal, tubercular, malarial, inflammatory and cancer diseases. Each of the categories of diseases has been discussed separately. The account of hybrid molecules developed against these diseases by the combination of natural products and synthetic molecules is given under different headings. The analysis should help shed light on the exciting field of molecular hybridization and may prove useful for the development of new drugs.
Autorenporträt
Palwinder Singh Randhawa, Ph.D.: Studied at Guru Nanak Dev University. Post-doc fellow at University of Vienna, Austria. Professor at Department of Chemistry, Guru Nanak Dev University Amritsar. Research interest: electronic structure analysis and molecular modeling based design of molecules to develop new molecules of medicinal importance.